- CureToday.com
- OncLive.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
All News
Petros Grivas, MD, PhD, on Updates in Genitourinary Oncology From ASCO 2021
June 20, 2021
Petros Grivas, MD, PhD, regarding updates in genitourinary oncology that were read out at the meeting.
Phase 1/2 Trial of Frontline Eprenetapopt Plus Venetoclax and Azacitidine for TP53-Mutant AML Meets End Point
June 20, 2021
A trial of an eprenetapopt combination has met the prespecified primary efficacy end point in patients with acute myeloid leukemia harboring TP53 mutations.
Longer Follow-Up Shows Cilta-Cel Induces Deep, Durable Responses in Relapsed/Refractory MM
June 19, 2021
At the 18-month follow-up, the CAR T-cell therapy led to early, deep, and durable responses with a manageable safety profile in patients with relapsed/refractory multiple myeloma.